Indeed, a significant increase in TENM3 mRNA and protein expression levels was observed when exogenous Wnt3a, a canonical Wnt ligand, is administered to neuroblastoma cells [86] and human colon myofibroblasts [87]. The gene discussed is TENM3; the disease is neuroblastoma.